Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O75356
UPID:
ENTP5_HUMAN
Alternative names:
CD39 antigen-like 4; ER-UDPase; Ectonucleoside triphosphate diphosphohydrolase 5; Guanosine-diphosphatase ENTPD5; Inosine diphosphate phosphatase ENTPD5; Nucleoside diphosphatase; Uridine-diphosphatase ENTPD5
Alternative UPACC:
O75356; A1L4C5; Q96RX0
Background:
Nucleoside diphosphate phosphatase ENTPD5, known by various names such as ER-UDPase and Guanosine-diphosphatase ENTPD5, plays a crucial role in cellular processes. It specializes in hydrolyzing nucleoside diphosphates, favoring GDP, IDP, and UDP over ADP and CDP. This activity is vital in the endoplasmic reticulum for regulating protein reglucosylation, essential for glycoprotein folding and quality control.
Therapeutic significance:
Understanding the role of Nucleoside diphosphate phosphatase ENTPD5 could open doors to potential therapeutic strategies. Its involvement in protein reglucosylation and glycoprotein folding highlights its importance in cellular function and disease prevention.